• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

短小棒状杆菌- PER对新西兰黑/白狼疮鼠模型疾病进展的影响。

Influence of Corynebacterium parvum-PER on disease progression in the NZB/W model of systemic lupus erythematosus.

作者信息

Krause G, Martin L, Fritzler M, Hart D A

机构信息

Joint Injury and Diseases Research Group, Faculty of Medicine, University of Calgary, Alberta, Canada.

出版信息

Int J Immunopharmacol. 1992 Jan;14(1):35-41. doi: 10.1016/0192-0561(92)90102-q.

DOI:10.1016/0192-0561(92)90102-q
PMID:1582732
Abstract

Murine models of systemic lupus erythematosus (SLE) exhibit some, but not all, of the characteristics of human disease. Disease progression in the animal models is regulated by autoantibodies, genetics and inflammatory processes. In the present study, the influence of the pyridine extract residue of Corynebacterium parvum Type I (CP-PER) on disease progression in the NZB/W model of SLE was investigated. CP-PER is known to activate the reticuloendothelial (RE) system of mice and can alter a number of host responses. Injection of NZB/W females with CP-PER at 10 weeks of age, prior to the onset of overt disease, led to a transient activation of the RE system which then appeared to return to levels observed in untreated animals. Sera from treated and untreated animals were analyzed for anti-nuclear antibodies, and anti-ssDNA antibodies. The most prominant change in the treated animals was an increase in the titer of anti-ssDNA. On average, animals in the early treatment group also lived somewhat longer than those in the untreated control group. Treatment of animals with CP-PER at 6 months of age, when the disease was evident, again led to transient RES activation and an altered autoantibody profile. Animals treated with CP-PER at 6 months of age exhibited a slightly accelerated death rate when compared with the untreated controls. These results indicate that bacterial response modifiers such as C. parvum-PER, which contains primarily the RES activating activity of C. parvum, can alter disease progression in the NZB/W model.

摘要

系统性红斑狼疮(SLE)的小鼠模型展现出了人类疾病的一些而非全部特征。动物模型中的疾病进展受自身抗体、遗传学和炎症过程调控。在本研究中,对I型微小棒状杆菌的吡啶提取物残渣(CP-PER)对SLE的NZB/W模型中疾病进展的影响进行了研究。已知CP-PER可激活小鼠的网状内皮(RE)系统,并能改变许多宿主反应。在明显疾病发作之前,于10周龄给NZB/W雌性小鼠注射CP-PER,导致RE系统短暂激活,随后似乎恢复到未处理动物中观察到的水平。对处理和未处理动物的血清进行抗核抗体和抗单链DNA抗体分析。处理组动物中最显著的变化是抗单链DNA滴度增加。平均而言,早期处理组的动物也比未处理的对照组动物存活时间稍长。在6月龄疾病明显时用CP-PER处理动物,再次导致RE系统短暂激活和自身抗体谱改变。与未处理的对照组相比,6月龄用CP-PER处理的动物死亡率略有加速。这些结果表明,诸如微小棒状杆菌-PER这类主要含有微小棒状杆菌RE激活活性的细菌反应调节剂,可改变NZB/W模型中的疾病进展。

相似文献

1
Influence of Corynebacterium parvum-PER on disease progression in the NZB/W model of systemic lupus erythematosus.短小棒状杆菌- PER对新西兰黑/白狼疮鼠模型疾病进展的影响。
Int J Immunopharmacol. 1992 Jan;14(1):35-41. doi: 10.1016/0192-0561(92)90102-q.
2
Influence of biological response modifiers of bacterial origin on disease progression in the MRL-lpr model of systemic lupus erythematosus.细菌来源的生物反应调节剂对系统性红斑狼疮MRL-lpr模型疾病进展的影响。
Clin Invest Med. 1991 Feb;14(1):55-62.
3
Partial characterization of the enhanced survival of female NZB/W mice treated with lithium chloride.
Int J Immunopharmacol. 1994 Oct;16(10):825-33. doi: 10.1016/0192-0561(94)90056-6.
4
An Ig mu-heavy chain transgene inhibits systemic lupus erythematosus immunopathology in autoimmune (NZB x NZW)F1 mice.一种免疫球蛋白μ重链转基因可抑制自身免疫性(NZB×NZW)F1小鼠的系统性红斑狼疮免疫病理学。
Int Immunol. 2001 Dec;13(12):1461-9. doi: 10.1093/intimm/13.12.1461.
5
Ongoing immunologic activity after short courses of pulse cyclophosphamide in the NZB/W murine model of systemic lupus erythematosus.在NZB/W系统性红斑狼疮小鼠模型中,短疗程脉冲环磷酰胺治疗后的持续免疫活性。
J Rheumatol. 1997 Jan;24(1):61-8.
6
Soluble human CD83 ameliorates lupus in NZB/W F1 mice.可溶性人 CD83 可改善 NZB/W F1 小鼠的狼疮。
Immunobiology. 2013 Nov;218(11):1411-5. doi: 10.1016/j.imbio.2013.06.002. Epub 2013 Jun 17.
7
A peptide derived from an autoantibody can stimulate T cells in the (NZB x NZW)F1 mouse model of systemic lupus erythematosus.一种源自自身抗体的肽可在系统性红斑狼疮的(新西兰黑鼠×新西兰白鼠)F1小鼠模型中刺激T细胞。
Arthritis Rheum. 1993 Mar;36(3):355-64. doi: 10.1002/art.1780360311.
8
The treatment of systemic lupus erythematosus (SLE) in NZB/W F1 hybrid mice; studies with recombinant murine DNase and with dexamethasone.NZB/W F1 杂交小鼠系统性红斑狼疮(SLE)的治疗;重组鼠脱氧核糖核酸酶和地塞米松的研究
Clin Exp Immunol. 1996 Nov;106(2):243-52. doi: 10.1046/j.1365-2249.1996.d01-839.x.
9
Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.IgM 同种型抗双链 DNA 抗体对(NZB×NZW)F1 小鼠狼疮疾病的抑制作用。
Arthritis Rheum. 2005 Nov;52(11):3629-38. doi: 10.1002/art.21379.
10
Plasma proteinase regulation during disease progression in murine models of SLE.系统性红斑狼疮小鼠模型疾病进展过程中的血浆蛋白酶调节
J Clin Lab Immunol. 1989 Sep;30(1):27-34.

引用本文的文献

1
Racial Differences in Plasma Microbial Translocation and Plasma Microbiome, Implications in Systemic Lupus Erythematosus Disease Pathogenesis.血浆微生物易位及血浆微生物群的种族差异对系统性红斑狼疮疾病发病机制的影响
ACR Open Rheumatol. 2024 Jun;6(6):365-374. doi: 10.1002/acr2.11664. Epub 2024 Apr 2.